Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739115 · ClinicalTrials.gov registry record · NA
The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study
A NA study, sponsored by Hawaii Pacific Health.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00739115 is a NA study that has completed, run by Hawaii Pacific Health. The registered enrollment target is 13 participants.
The verdict
NCT00739115, a NA study, has completed, sponsored by Hawaii Pacific Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and utility of using heliox gas in combination with nasal CPAP in premature infants. The investigators hypothesize that using heliox gas in combination with nasal CPAP will results in decreased early nasal CPAP failure requiring intubation and mechanical ventilation.
Interventions
- OTHER Heliox gas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00739115
The ClinicalTrials.gov registry entry for NCT00739115 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hawaii Pacific Health, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Heliox gas is the first listed.
NCT00739115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00739115 about?
NCT00739115 is a clinical study titled "The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study". The purpose of this study is to evaluate the safety and utility of using heliox gas in combination with nasal CPAP in premature infants. The investigators hypothesize that using heliox gas in combination with nasal CPAP will results in decreased early nasal CPAP failure requiring intubation and mech...
What is the current status of trial NCT00739115?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2008-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00739115?
The interventions under investigation include: Heliox gas (OTHER).
Who is sponsoring clinical trial NCT00739115?
This trial is sponsored by Hawaii Pacific Health, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.